Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Written by ClinicalTrials.gov

Category: Bone diseases

Published: 19 July 2011

Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2 transdermal (Julina, BAY86-5435)
Sponsor: Bayer
Recruiting - verified August 2011

Details: Last Updated: 19 July 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies